Literature DB >> 23928672

PTH: a new target in arteriosclerosis?

Petra J Buizert1, Natasja M van Schoor, Suat Simsek, Paul Lips, A C Heijboer, M den Heijer, Dorly J H Deeg, Elisabeth M W Eekhoff.   

Abstract

CONTEXT: Growing evidence demonstrates that hyperparathyroidism is associated with an increased risk of cardiovascular morbidity and mortality. However, little is known about the relation between serum PTH levels within the normal range and cardiovascular diseases (CVD).
OBJECTIVE: In this study the relationship of serum PTH levels within the normal range with CVD and abdominal aortic calcifications was investigated.
DESIGN: A cross-sectional, population-based study was performed using data of the Longitudinal Aging Study Amsterdam, including 558 men and 537 women, aged 65-88 years. Models were controlled for sex, age, body mass index, hypertension, diabetes mellitus, high-density lipoprotein cholesterol, total cholesterol, smoking, physical activity, alcohol consumption, glomerular filtration rate, season of blood collection, calcium or diuretic use, and serum 25-hydroxyvitamin D and osteocalcin levels when these variables were found to be relevant confounders.
RESULTS: Multivariate models showed that subjects in the highest quintile of serum PTH had a significantly higher risk of CVD as compared with subjects in the lowest quintile (odds ratio 2.22, confidence interval 1.39-3.56). The relationship between PTH and abdominal aortic calcifications was observed only in men, which remained significant after adjusting for confounders (odds ratio 4.03, confidence interval 1.50-10.83).
CONCLUSIONS: This study demonstrated that in older persons the presence of serum PTH levels within the upper normal range is highly related to CVD. In men, this association may partly be explained by calcifications of the abdominal aorta. Because CVD poses an important health risk, further elucidation of the role of serum PTH in CVD and arteriosclerosis is relevant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928672     DOI: 10.1210/jc.2013-1621

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

2.  Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure.

Authors:  Gang-Yong Wu; Bai-Da Xu; Ting Wu; Xiao-Ying Wang; Tian-Xiao Wang; Xiao Zhang; Xiao Wang; Yang Xia; Gang-Jun Zong
Journal:  Biomed Rep       Date:  2016-09-26

3.  Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism.

Authors:  Didem Ozdemir; Gulhan Yuksel Kalkan; Nihal Akar Bayram; Eda Demir Onal; Reyhan Ersoy; Engin Bozkurt; Bekir Cakir
Journal:  Endocrine       Date:  2014-03-28       Impact factor: 3.633

4.  Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.

Authors:  M Procopio; M Barale; S Bertaina; S Sigrist; R Mazzetti; M Loiacono; G Mengozzi; E Ghigo; M Maccario
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

Review 5.  Assessing the health impact of phosphorus in the food supply: issues and considerations.

Authors:  Mona S Calvo; Alanna J Moshfegh; Katherine L Tucker
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

6.  Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: A long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden.

Authors:  Georgios Kontogeorgos; Penelope Trimpou; Christine M Laine; Göran Oleröd; Anders Lindahl; Kerstin Landin-Wilhelmsen
Journal:  Clin Endocrinol (Oxf)       Date:  2015-06-15       Impact factor: 3.478

Review 7.  Serum Parathyroid Hormone Responses to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Ashley Lotito; Masaru Teramoto; May Cheung; Kendra Becker; Deeptha Sukumar
Journal:  Nutrients       Date:  2017-03-06       Impact factor: 5.717

8.  Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism.

Authors:  Jessica Pepe; Cristiana Cipriani; Massimiliano Tedeschi; Mario Curione; Mariacristina Parravano; Monica Varano; Federica Biamonte; Luciano Colangelo; Salvatore Minisola
Journal:  Sci Rep       Date:  2018-11-08       Impact factor: 4.379

9.  Racial/Ethnic Differences in 25-Hydroxy Vitamin D and Parathyroid Hormone Levels and Cardiovascular Disease Risk Among Postmenopausal Women.

Authors:  Xi Zhang; Wanzhu Tu; JoAnn E Manson; Lesley Tinker; Simin Liu; Jane A Cauley; Lihong Qi; Charles Mouton; Lisa W Martin; Lifang Hou; Yiqing Song
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

10.  The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findings.

Authors:  Emiel O Hoogendijk; Dorly J H Deeg; Jan Poppelaars; Marleen van der Horst; Marjolein I Broese van Groenou; Hannie C Comijs; H Roeline W Pasman; Natasja M van Schoor; Bianca Suanet; Fleur Thomése; Theo G van Tilburg; Marjolein Visser; Martijn Huisman
Journal:  Eur J Epidemiol       Date:  2016-08-20       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.